Relationship Between Serotonin and Brain Response to Social Dominance and Emotion Perception.
NCT ID: NCT03041870
Last Updated: 2019-07-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2017-11-14
2019-06-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multicenter Comparative Study of the Activity of the Medial Prefrontal Cortex in Vulnerability to Depression
NCT02171923
Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion Processing
NCT03019822
Pain in Parkinson's Disease: Exploration of the Serotonin System in Positron Emission Tomography (PET [18F]-MPPF)
NCT06008704
Motivation, Learning and Decision Making in Changing Environments
NCT07314112
Investigating Stress-Induced Dopamine Release: a fMRI-PET Study
NCT05825677
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dominance
Healthy subjects
PET-fMRI scan
fMRI scan include MR sequences: BOLD and fMRI. The PET acquisition will be carried out in dynamic for 90 consecutive minutes following intravenous administration of 4 MBq / kg dose of \[11C\]DASB bolus.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PET-fMRI scan
fMRI scan include MR sequences: BOLD and fMRI. The PET acquisition will be carried out in dynamic for 90 consecutive minutes following intravenous administration of 4 MBq / kg dose of \[11C\]DASB bolus.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal vision
* Age from 18 to 45
* Without psychiatric antecedent
* Without any neurologic antecedent
* Not taking psychotropic or anxiolytic drugs
* Having health insurance coverage
Exclusion Criteria
* Subjects suffering from claustrophobia
* Subjects carrying magnetic metal objects that cannot be removed as cochlear implant, surgical clips, piercings, pacemakers, mechanical valves
* Subjects participating in a clinical trial or being in a period of exclusion from a previous clinical trial
* Person under guardianship or curatorship or deprived of liberty or in emergencies
* Taking unauthorized treatment in the month before the completion of the review
* Person whose physical or mental condition does not allow him to pass the test study
18 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian SCHEIBER
Role: PRINCIPAL_INVESTIGATOR
Hospices Civils de Lyon - CNRS UMR 5229
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospices Civils de Lyon
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-A01588-43
Identifier Type: OTHER
Identifier Source: secondary_id
69HCL16_0014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.